On May 21, 2025, the European Union notified the WTO (G/TBT/N/EU/1140) of its proposal to amend the EU Cosmetics Regulation (EC) No 1223/2009. The amendment seeks to add 15 substances classified as carcinogenic, mutagenic, or toxic for reproduction (CMR) to Annex II (List of Prohibited Substances). It also proposes updates to Annex III (List of Restricted Substances), Annex IV (List of Permitted Colorants), and Annex V (List of Permitted Preservatives). The regulation will take effect 20 days after its publication in the Official Journal of the European Union and will apply from May 1, 2026.
Regulatory Interpretation
This amendment primarily concerns CMR substances classified as Category 1A, 1B, or 2 under Regulation (EU) 2024/2564. In September 2024, the European Commission published Commission Delegated Regulation (EU) 2024/2564 of June 19, 2024, which amends the Classification, Labelling and Packaging (CLP) Regulation. The amendment mainly updates the harmonized classification and labelling list in Part 3 of Annex VI to the CLP Regulation, covering substances such as Sodium Perborate (CAS No. 7632-04-4) and Silver (CAS No. 7440-22-4). This amendment will enter into force on May 1, 2026.
Proposed Amendments
(1) Annex II is amended as follows:
(a) Entry 1397 is replaced by the following:
Reference |
Substance identification |
||
Chemical name/INN |
CAS number |
EC number |
|
a |
b |
c |
d |
1397 |
Perboric acid (H3BO2(O2)), monosodium salt trihydrate [1]; |
13517-20-9 [1] |
239-172-9 [1] |
Perboric acid, sodium salt, tetrahydrate [2]; |
37244-98-7 [2] |
234-390-0 [2] |
|
Perboric acid (HBO(O2)), sodium salt, tetrahydrate [3]; |
10486-00-7 [3] |
- [3] |
|
Sodium peroxoborate, hexahydrate [4]; |
- [4] |
- [4] |
|
Sodium perborate [5]; |
15120-21-5 [5] |
239-172-9 [5] |
|
Sodium peroxometaborate; sodium peroxoborate [6]; |
7632-04-4/ 10332-33-9/ 10486-00-7 [6] |
231-556-4 [6] |
|
Perboric acid, sodium salt [7]; |
11138-47-9 [7] |
234-390-0 [7] |
|
Perboric acid, sodium salt, monohydrate [8]; |
12040-72-1 [8] |
234-390-0 [8] |
|
Perboric acid (HBO(O2)), sodium salt, monohydrate [9]; |
10332-33-9 [9] |
- [9] |
(b) Entries 1398 and 1399 are deleted;
(c) Entry 1727 is replaced by the following:
Reference |
Substance identification |
||
Chemical name/INN |
CAS number |
EC number |
|
a |
b |
c |
d |
1727 |
Silver (nano) [1 nm < particle diameter≤100 nm]; Silver (massive) [particle diameter≥1 mm] |
7440-22-4 |
231-131-3 |
(d) The following entries are added:
Reference |
Substance identification |
||
Chemical name/INN |
CAS number |
EC number |
|
a |
b |
c |
d |
Replace with the next consecutive number |
Multi-walled Carbon Tubes (synthetic graphite in tubular shape) with a geometric tube diameter range≥30 nm to < 3 µm and a length≥5 µm and aspect ratio > 3:1, including Multi-Walled Carbon Nanotubes, MWC(N)T |
- |
- |
reaction mass of 1,3-dioxan-5-ol and 1,3-dioxolan-4-ylmethanol |
- |
- |
|
Acetone oxime |
127-06-0 |
204-820-1 |
|
2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one |
119344-86-4 |
438-340-0 |
|
2,3-epoxypropyl neodecanoate |
26761-45-5 |
247-979-2 |
|
Benthiavalicarb-isopropyl (ISO); isopropyl [(S)-1-{[(R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamate |
177406-68-7 |
- |
|
7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate |
2386-87-0 |
219-207-4 |
|
Sodium 3-(allyloxy)-2-hydroxypropanesulphonate |
52556-42-0 |
258-004-5 |
|
Replace with the next consecutive number |
1,4-dichloro-2-nitrobenzene |
89-61-2 |
201-923-3 |
Replace with the next consecutive number |
Fenpropidin (ISO); (R,S)-1-[3-(4-tertbutylphenyl)-2-methylpropyl]piperidine |
67306-00-7 |
- |
Replace with the next consecutive number |
N,N'-methylenediacrylamide |
110-26-9 |
203-750-9 |
Replace with the next consecutive number |
tert-butyl 2-ethylperoxyhexanoate |
3006-82-4 |
221-110-7 |
Replace with the next consecutive number |
Trimethyl borate |
121-43-7 |
204-468-9 |
Replace with the next consecutive number |
S-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (RaSa)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100% 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide and 0-20% 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide] |
87392-12-9 |
- |
Replace with the next consecutive number |
Pyraclostrobin (ISO); methyl N-(2-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl}phenyl) N-methoxy carbamate |
175013-18-0 |
- |
(2) In Annex III, the following entries are added:
Reference number |
Substance identification |
Restrictions |
Wording of conditions of use and warnings |
|||||
Chemical Name /INN |
Name of Common Ingredients Glossary |
CAS number |
EC number |
Product type |
Maximum concentration in ready for use preparation |
Other |
||
a |
b |
c |
d |
e |
f |
g |
h |
i |
Replace with the next consecutive number |
Silver (powder) [100 nm < particle diameter < 1 mm] |
Silver |
7440-22-4 |
231-131-3 |
(a) Toothpaste (b) Mouthwash |
For (a) and (b): 0.05 % |
||
Replace with the next consecutive number |
Hexyl 2-hydroxybenzoate |
Hexyl Salicylate |
6259-76-3 |
228-408-6 |
(a) Hydroalcoholic-based fragrances (b) All rinse-off products (except shower gel, hand wash, hair conditioner and shampoo intended for children below 3 years of age) (c) All leave-on products (except hair conditioner, body lotion, face cream, hand cream, lipstick/lip balm and fragrance products intended for children below 3 years of age) (d) Toothpaste (e) Mouthwash (f) Shower gel, hand wash, shampoo, hair conditioner, body, face and hand (skin) care products, lipstick/lip balm and fragrance products intended for children below 3 years of age |
(a) 2 % (b) 0.5 % (c) 0.3 % (d) 0.001 % (e) 0.001 % (f) 0.1 % |
Not to be used in preparations for children under 3 years of age, with the exception of (d) “Toothpaste and (f). |
(e) Not to be used for children under 3 years of age |
(3) In Annex IV, entry 142 is replaced by the following:
Reference |
Substance identification |
Conditions |
Wording of conditions of use and warnings |
||||||
Chemical name |
Colour index Number/Name of Common Ingredients Glossary |
CAS |
EC |
Colour |
Product type |
Maximum concentration in ready for use preparation |
Other |
||
a |
b |
c |
d |
e |
f |
g |
h |
i |
j |
142 |
Silver (powder) [100 nm < particle diameter< 1 mm] |
Silver |
7440-22-4 |
231-131-3 |
White |
(a) Lip products (b) Eye shadow |
For (a) and (b): 0.2 % |
(4) In Annex V, entry 7 is replaced by the following:
Reference |
Substance identification |
Conditions |
Wording of conditions of use and warnings |
|||||
Chemical name/INN |
Name of common ingredients glossary |
CAS |
EC |
Product type |
Maximumconcentration in |
Other |
||
a |
b |
c |
d |
e |
f |
g |
h |
i |
7 |
Biphenyl-2-ol; 2- phenylphenol; 2-hydroxybiphenyl |
o-Phenylphenol Sodium o- |
90-43-7 132-27-4 |
201-993-5 205-055-6 |
(a) Rinse-off products (b) Leave-on products |
(a) 0.2 % (as phenol (b) 0.15 % (as phenol) |
When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0.2 % in rinse-off and 0.15 % in leave-on products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products. |
Avoid contact with eyes |
About CIRS
The CIRS cosmetic team is dedicated to ensuring that cosmetic products meet stringent global regulatory standards. It can provide one-stop services covering the whole life-cycle of a personal care product, which includes cosmetic ingredient development, physical/chemical tests, toxicological tests (in vivo & in vitro), efficacy studies (in vivo & in vitro), ingredient registration, and product registration.
Our Services
- EU Cosmetic Product Formula and Label Review;
- EU Cosmetic Responsible Person;
- Product Information File (PIF); and
- EU Cosmetic Safety Assessment (CPSR)
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.
Further Information
https://members.wto.org/crnattachments/2025/tbt/EEC/25_03493_00_e.pdf
https://members.wto.org/crnattachments/2025/tbt/EEC/25_03493_01_e.pdf